Bicycle Therapeutics (BCYC) Price & Analysis

Compare

403 Followers

BCYC Stock Chart & Stats

$7.19

-$0.24(-1.59%)

At close: Jan 08 4:00 PM EST

$7.19

-$0.24(-1.59%)

Day’s Range― - ―

52-Week Range$6.03 - $15.47

Previous CloseN/A

Volume92.63K

Average Volume (3M)287.41K

Market Cap

$498.31M

Enterprise Value-$105.43M

Total Cash (Recent Filing)$648.33M

Total Debt (Recent Filing)$5.74M

Price to Earnings (P/E)―

Beta1.59

Next Earnings

Mar 03, 2026

EPS Estimate

-0.94

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.85

Shares Outstanding49,929,950

10 Day Avg. Volume252,636

30 Day Avg. Volume287,414

Financial Highlights & Ratios

PEG Ratio0.11

Price to Book (P/B)1.03

Price to Sales (P/S)23.10

P/FCF Ratio-4.91

Enterprise Value/Market Cap-0.21

Enterprise Value/Revenue-3.72

Enterprise Value/Gross Profit0.68

Enterprise Value/Ebitda0.39

Forecast

1Y Price Target

$20.75

Price Target Upside188.60% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering9

EPS Forecast (FY)-3.86

Revenue Forecast (FY)$32.40M

Bulls Say, Bears Say

Bulls Say

Financial PerformanceThe company reported revenues of $11.7M with a net loss of $0.85 per diluted share, beating consensus estimated revenues of $8.0M with a net loss of $1.08.

Regulatory EngagementThe zele update will now include feedback from multiple regulatory agencies, rather than solely on the feedback of the FDA.

Strategic DevelopmentsThe decision to seek regulatory feedback is seen as a positive indicator for the progress of the data.

Bears Say

Regulatory DelaysThe dose selection from the Ph 2/3 Duravelo-2 study has been delayed to obtain alignment with regulatory agencies.

Bicycle Therapeutics News

Bicycle signs 15-year uranium contract with UK Nuclear Decommissioning Authority

Bicycle Therapeutics (BCYC) announced it has entered into a 15-year contract including an option to renew with the...

8d ago

BCYC

Bicycle Therapeutics initiated with a Hold at Truist

Truist initiated coverage of Bicycle Therapeutics (BCYC) with a Hold rating and $10 price target The time to...

1M ago

BCYC

Buy Rating for Bicycle Therapeutics: Strong Upside Potential Amid Clinical and Financial Developments

Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Bicycle Therapeutics and keeping the price target...

2M ago

BCYC

Bicycle Therapeutics price target raised to $12 from $10 at Citizens JMP

Citizens JMP analyst Reni Benjamin raised the firm’s price target on Bicycle Therapeutics (BCYC) to $12 from $10...

2M ago

BCYC

RBC downgrades Bicycle Therapeutics on slow pipeline progress

RBC Capital analyst Leonid Timashev last night downgraded Bicycle Therapeutics (BCYC) to Sector Perform from Outperform with a...

2M ago

BCYC

Bicycle Therapeutics Reports Q3 2025 Financial Results

Bicycle Therapeutics ( ($BCYC) ) has released its Q3 earnings. Here is a breakdown of the information Bicycle...

2M ago

BCYC

Bicycle Therapeutics downgraded to Sector Perform at RBC Capital

RBC Capital analyst Leonid Timashev downgraded Bicycle Therapeutics (BCYC) to Sector Perform from Outperform with a price target...

2M ago

BCYC

Strategic Regulatory Alignment and Positive Momentum Justify Buy Rating for Bicycle Therapeutics

Needham analyst Ami Fadia has reiterated their bullish stance on BCYC stock, giving a Buy rating today. Ami...

2M ago

BCYC

Bicycle Therapeutics reports Q3 EPS (85c), consensus ($1.07)

Reports Q3 revenue $11.73M, consensus $8.25M. “We are currently seeking broad regulatory feedback to make an informed decision...

2M ago

BCYC

Bicycle Therapeutics Expands Board with New Appointments

Bicycle Therapeutics ( ($BCYC) ) has provided an announcement. On September 8, 2025, Bicycle Therapeutics announced the expansion...

4M ago

BCYC

Bicycle Therapeutics price target lowered to $10 from $22 at Citizens JMP

Citizens JMP lowered the firm’s price target on Bicycle Therapeutics (BCYC) to $10 from $22 and keeps an...

4M ago

BCYC

Bicycle Therapeutics Reports Q2 2025 Financial Results

Bicycle Therapeutics ( ($BCYC) ) has released its Q2 earnings. Here is a breakdown of the information Bicycle...

4M ago

BCYC

Bicycle Therapeutics price target raised to $27 from $25 at RBC Capital

RBC Capital analyst Leonid Timashev raised the firm’s price target on Bicycle Therapeutics (BCYC) to $27 from $25...

5M ago

BCYC

Bicycle Therapeutics price target lowered to $44 from $48 at Oppenheimer

Oppenheimer analyst Jay Olson lowered the firm’s price target on Bicycle Therapeutics (BCYC) to $44 from $48 and...

5M ago

BCYC

BCYC FAQ

What was Bicycle Therapeutics Ltd’s price range in the past 12 months?

Bicycle Therapeutics Ltd lowest stock price was $6.03 and its highest was $15.47 in the past 12 months.

What is Bicycle Therapeutics Ltd’s market cap?

Bicycle Therapeutics Ltd’s market cap is $498.31M.

When is Bicycle Therapeutics Ltd’s upcoming earnings report date?

Bicycle Therapeutics Ltd’s upcoming earnings report date is Mar 03, 2026 which is in 69 days.

How were Bicycle Therapeutics Ltd’s earnings last quarter?

Bicycle Therapeutics Ltd released its earnings results on Oct 30, 2025. The company reported -$0.85 earnings per share for the quarter, beating the consensus estimate of -$1.078 by $0.228.

Is Bicycle Therapeutics Ltd overvalued?

According to Wall Street analysts Bicycle Therapeutics Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Bicycle Therapeutics Ltd pay dividends?

Bicycle Therapeutics Ltd does not currently pay dividends.

What is Bicycle Therapeutics Ltd’s EPS estimate?

Bicycle Therapeutics Ltd’s EPS estimate is -0.94.

How many shares outstanding does Bicycle Therapeutics Ltd have?

Bicycle Therapeutics Ltd has 49,929,950 shares outstanding.

What happened to Bicycle Therapeutics Ltd’s price movement after its last earnings report?

Bicycle Therapeutics Ltd reported an EPS of -$0.85 in its last earnings report, beating expectations of -$1.078. Following the earnings report the stock price went up 7.09%.

Which hedge fund is a major shareholder of Bicycle Therapeutics Ltd?

Currently, no hedge funds are holding shares in BCYC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Bicycle Therapeutics Stock Smart Score

Underperform

Fundamentals

Return on Equity

-34.63%

Trailing 12-Months

Asset Growth

-23.36%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Bicycle Therapeutics Ltd

Bicycle Therapeutics (BCYC) is a biotechnology company focused on developing a new class of medicines known as bicyclic peptide therapeutics. Leveraging its proprietary bicyclic peptide platform, the company aims to create innovative treatments primarily in the fields of oncology and other serious diseases. Bicycle Therapeutics is dedicated to addressing unmet medical needs by harnessing the unique properties of bicyclic peptides, which offer advantages such as enhanced stability, solubility, and targeted delivery compared to traditional therapeutic modalities.

Bicycle Therapeutics (BCYC) Earnings & Revenues

Historic Earnings Reports

BCYC Stock 12 Month Forecast

Average Price Target

$20.75

▲(188.60% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","45":"$45","15.75":"$15.75","25.5":"$25.5","35.25":"$35.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":44,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$44.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$20.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$10.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,15.75,25.5,35.25,45],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.07,10.833846153846153,13.597692307692308,16.361538461538462,19.125384615384615,21.889230769230767,24.653076923076924,27.416923076923077,30.18076923076923,32.94461538461538,35.708461538461535,38.472307692307695,41.23615384615385,{"y":44,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.07,9.045384615384616,10.02076923076923,10.996153846153847,11.971538461538461,12.946923076923078,13.922307692307694,14.897692307692308,15.873076923076923,16.84846153846154,17.823846153846155,18.799230769230768,19.774615384615387,{"y":20.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.07,8.218461538461538,8.366923076923078,8.515384615384615,8.663846153846155,8.812307692307693,8.96076923076923,9.10923076923077,9.257692307692308,9.406153846153845,9.554615384615385,9.703076923076923,9.851538461538462,{"y":10,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.71,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.01,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.39,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.97,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.85,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.08,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.55,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.03,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.99,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.2,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.33,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.07,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >